|
infant |
20 |
|
humans |
19 |
|
male |
17 |
|
cadaver |
13 |
|
female |
13 |
|
hong kong - epidemiology |
13 |
|
treatment outcome |
13 |
|
child |
12 |
|
child, preschool |
12 |
|
graft survival |
12 |
|
pediatric liver transplantation |
12 |
|
follow-up studies |
11 |
|
intraoperative complications - epidemiology |
11 |
|
liver transplantation - statistics & numerical data |
11 |
|
survival rate |
11 |
|
adolescent |
10 |
|
age factors |
10 |
|
immunosuppressive agents - therapeutic use |
10 |
|
liver diseases - surgery |
10 |
|
liver transplantation - methods - statistics and numerical data |
10 |
|
living donors - supply and distribution |
10 |
|
scarce deceased donors |
10 |
|
time factors |
10 |
|
tissue donors - supply and distribution |
10 |
|
hospitals, university |
9 |
|
liver diseases - epidemiology |
9 |
|
postoperative complications - epidemiology |
9 |
|
prognosis |
9 |
|
biliary atresia - complications - surgery |
8 |
|
chemicals and cas registry numbers |
8 |
|
complications of liver transplantation |
8 |
|
cyclosporine - therapeutic use |
8 |
|
drug therapy, combination |
8 |
|
incidence |
8 |
|
liver diseases - etiology - surgery |
8 |
|
liver transplantation - adverse effects - statistics & numerical data |
8 |
|
liver transplantation - contraindications - methods - mortality - statistics & numerical data |
8 |
|
liver transplantation - methods |
8 |
|
living donor liver transplant |
8 |
|
living donors |
8 |
|
living-related liver transplantation |
8 |
|
medical sciences |
8 |
|
pediatric liver transplant |
8 |
|
portoenterostomy, hepatic |
8 |
|
postoperative complications - classification - epidemiology |
8 |
|
reduced-size liver transplant |
8 |
|
reduced-size liver transplantation |
8 |
|
retrospective studies |
8 |
|
tissue donors |
8 |
|
tissue donors - statistics & numerical data |
8 |
|
activities of daily living |
7 |
|
adult |
7 |
|
anastomosis, roux-en-y |
7 |
|
anastomosis, surgical - methods |
7 |
|
bile duct diseases - etiology |
7 |
|
bile ducts - blood supply - surgery |
7 |
|
biliary atresia |
7 |
|
bilirubin - blood |
7 |
|
body weight |
7 |
|
cadaveric transplantation |
7 |
|
graft rejection |
7 |
|
hepatic artery - surgery |
7 |
|
hepatitis - surgery |
7 |
|
histocompatibility |
7 |
|
hong kong |
7 |
|
liver diseases - congenital - mortality - surgery |
7 |
|
liver diseases - epidemiology - surgery |
7 |
|
liver failure - surgery |
7 |
|
liver function tests |
7 |
|
liver transplantation |
7 |
|
liver transplantation - adverse effects - methods - mortality |
7 |
|
liver transplantation - adverse effects - methods - pathology - statistics & numerical data |
7 |
|
liver transplantation - methods - physiology |
7 |
|
living donors - classification |
7 |
|
microsurgery |
7 |
|
microvascular anastomosis |
7 |
|
olt |
7 |
|
organ size |
7 |
|
postoperative complications |
7 |
|
postoperative complications - prevention & control - surgery |
7 |
|
registries |
7 |
|
reoperation |
7 |
|
stents |
7 |
|
thrombosis - prevention & control |
7 |
|
vascular surgical procedures - methods |
7 |
|
hyperinsulinism |
6 |
|
hypoglycaemia |
6 |
|
infant, newborn |
6 |
|
management |
6 |
|
hepatectomy - methods |
5 |
|
liver transplantation - immunology - methods - physiology |
5 |
|
middle aged |
5 |
|
nuclear family |
5 |
|
patient selection |
5 |
|
factor xii deficiency - complications - ethnology |
4 |
|
fatty acids, omega-3 - administration & dosage |
4 |
|
graft rejection - drug therapy - pathology |
4 |
|
hematoma, subdural - etiology |
4 |
|
immunosuppression - methods |
4 |
|
liver transplantation - immunology - pathology |
4 |
|
short bowel syndrome - drug therapy |
4 |
|
chinese |
3 |
|
cystic adenomatoid malformation of lung, congenital |
3 |
|
endotracheal intubation |
3 |
|
enzyme replacement |
3 |
|
foreign body |
3 |
|
hematopoietic stem cell transplant |
3 |
|
intensive care |
3 |
|
iron chelator |
3 |
|
pediatric |
3 |
|
pompe disease |
3 |
|
premature infant |
3 |
|
prenatal diagnosis |
3 |
|
rhizopus |
3 |
|
scoring system |
3 |
|
zygomycosis |
3 |
|
acetaminophen - administration & dosage - adverse effects |
2 |
|
airway obstruction |
2 |
|
airway obstruction - complications - diagnosis |
2 |
|
analgesics, non-narcotic - adverse effects - analysis |
2 |
|
analysis of variance |
2 |
|
anaphylaxis - chemically induced - physiopathology |
2 |
|
birth weight - physiology |
2 |
|
blood flow velocity - physiology |
2 |
|
bronchoscopy - methods |
2 |
|
chi-square distribution |
2 |
|
congenital heart disease |
2 |
|
dose-response relationship, immunologic |
2 |
|
flexible bronchoscopy |
2 |
|
heart defects, congenital - complications |
2 |
|
hepatitis b antibodies - blood |
2 |
|
hepatitis b surface antigens - blood |
2 |
|
hepatitis b vaccines - immunology |
2 |
|
immunization schedule |
2 |
|
infant, low birth weight |
2 |
|
infant, premature - immunology |
2 |
|
infant, premature - physiology |
2 |
|
neonate |
2 |
|
peritoneal dialysis |
2 |
|
pulsatile flow - physiology |
2 |
|
respiratory system abnormalities - diagnosis |
2 |
|
vascular resistance - physiology |
2 |
|
acute renal failure |
1 |
|
ammonia blood - metabolism - urine |
1 |
|
anti-bacterial agents - pharmacology - therapeutic use |
1 |
|
bacillus |
1 |
|
bloodstream infections |
1 |
|
chinese children |
1 |
|
continuous arteriovenous haemofiltration |
1 |
|
continuous arteriovenous hemodiafiltration |
1 |
|
contrast-enhanced spiral ct angiography |
1 |
|
deep vein thrombosis (dvt) |
1 |
|
enterocolitis, pseudomembranous - drug therapy - microbiology |
1 |
|
gram-negative bacteria - drug effects - isolation & purification |
1 |
|
hemofiltration |
1 |
|
hemofiltration - economics - methods |
1 |
|
hospital design and construction |
1 |
|
hyperammonemia |
1 |
|
infant, premature, diseases - drug therapy - microbiology |
1 |
|
intensive care unit |
1 |
|
intensive care units, neonatal - economics - organization & administration |
1 |
|
intensive care units, pediatric - economics - organization & administration |
1 |
|
klebsiella - drug effects - isolation & purification |
1 |
|
lavage |
1 |
|
meconium aspiration syndrome |
1 |
|
metabolism, inborn errors - metabolism - therapy |
1 |
|
necrotizing enterocolitis |
1 |
|
normal children |
1 |
|
peritoneal dialysis, continuous ambulatory |
1 |
|
pre‐antibiotic bacteriology |
1 |
|
pseudomonas septicaemia |
1 |
|
pulmonary embolism (pe) |
1 |
|
pulmonary surfactants |
1 |
|
renal circulation - physiology |
1 |
|
renal replacement therapy - economics |
1 |
|
sepsis |
1 |
|
urea cycle disorder |
1 |
